{ }
001122334455554433221100
001122334455554433221100

Elite Pharmaceuticals Reports 33 Percent Revenue Growth and 84 Percent Profit Increase

Elite Pharmaceuticals, Inc. reported consolidated revenues of $18.9 million for Q2 FY2025, a 33% increase year-over-year, driven by strong sales in its Elite label product line. Operating profits surged 84% to $3.5 million compared to the same quarter last year. The company will host a conference call on November 15, 2024, to discuss these results and recent developments.

elite pharmaceuticals reports strong second quarter financial results for 2025

elite pharmaceuticals reports first quarter financial results for fiscal year 2025

Elite Pharmaceuticals, Inc. has announced its financial results for the first quarter of fiscal year 2025, which ended on June 30, 2024. The company also provided details regarding an upcoming conference call to discuss these results further.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.